GLP-1 use among young children with obesity in US remains rare but is rising rapidly

Although the fig of U.S. children nether property 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and Zepbound remains low, it was 310 times higher successful June 2026 than successful 2019, erstwhile the drugs were archetypal prescribed, a caller survey shows.